Potential offtaker

Dr. Reddy’s Laboratories Ltd.

www.drreddys.com

Estimated electricity consumption

N/A

Countries of production presence

N/A

Dr. Reddy’s Laboratories Ltd. is a leading Indian pharmaceutical company that operates in the generic pharma sector. The company was founded in 1984 by Dr. K. Anji Reddy, who was a renowned scientist and entrepreneur. Dr. Reddy’s Laboratories Ltd. has its headquarters in Hyderabad, India, and has a global presence with operations in over 25 countries.

The company’s mission is to provide affordable and accessible healthcare solutions to people around the world. Dr. Reddy’s Laboratories Ltd. is committed to innovation, quality, and sustainability in all its operations. The company has a strong focus on decarbonisation and reducing its carbon footprint through various initiatives.

Corporate Energy

Dr. Reddy’s Laboratories Ltd. has implemented several energy efficiency measures to reduce its energy consumption and carbon emissions. The company has invested in energy-efficient equipment and technologies, such as LED lighting and energy-efficient HVAC systems, to reduce its energy consumption. The company has also implemented a comprehensive energy management system to monitor and manage its energy consumption.

Dr. Reddy’s Laboratories Ltd. has also implemented a renewable energy program to reduce its dependence on fossil fuels. The company has installed solar panels at its manufacturing plants and offices to generate clean energy. The company’s solar power plants have a total capacity of 7.2 MW, which helps to reduce its carbon emissions by 10,000 tonnes per year.

Corporate PPA

Dr. Reddy’s Laboratories Ltd. has also entered into a corporate power purchase agreement (PPA) to source renewable energy from wind farms. The company has signed a 10-year PPA with a wind farm in Andhra Pradesh, India, to source 50 MW of renewable energy. The PPA will help the company to reduce its carbon emissions by 70,000 tonnes per year.

The corporate PPA is a significant step towards achieving the company’s sustainability goals. The PPA will help the company to reduce its dependence on fossil fuels and source clean energy at a competitive price. The PPA also demonstrates the company’s commitment to sustainability and decarbonisation.

Renewable Energy

Dr. Reddy’s Laboratories Ltd. is committed to sourcing renewable energy to reduce its carbon footprint. The company has set a target to source 50% of its energy from renewable sources by 2025. The company’s renewable energy program includes solar power, wind power, and biomass energy.

The company has installed solar panels at its manufacturing plants and offices to generate clean energy. The company’s solar power plants have a total capacity of 7.2 MW, which helps to reduce its carbon emissions by 10,000 tonnes per year. The company has also entered into a corporate PPA to source renewable energy from wind farms.

Dr. Reddy’s Laboratories Ltd. is also exploring the use of biomass energy to reduce its carbon footprint. The company is working on a project to convert agricultural waste into energy. The project will help to reduce the amount of agricultural waste that is burned, which contributes to air pollution and climate change.

Decarbonisation

Dr. Reddy’s Laboratories Ltd. is committed to decarbonisation and reducing its carbon footprint. The company has set a target to reduce its carbon emissions by 20% by 2025. The company’s decarbonisation program includes energy efficiency measures, renewable energy, and the use of biomass energy.

The company has implemented several energy efficiency measures to reduce its energy consumption and carbon emissions. The company has invested in energy-efficient equipment and technologies, such as LED lighting and energy-efficient HVAC systems, to reduce its energy consumption. The company has also implemented a comprehensive energy management system to monitor and manage its energy consumption.

Dr. Reddy’s Laboratories Ltd. is also committed to reducing its carbon emissions from transportation. The company has implemented a green logistics program to reduce its carbon emissions from transportation. The program includes the use of electric vehicles, hybrid vehicles, and biofuel-powered vehicles.

Conclusion

Dr. Reddy’s Laboratories Ltd. is a leading Indian pharmaceutical company that operates in the generic pharma sector. The company is committed to sustainability and decarbonisation in all its operations. The company has implemented several initiatives to reduce its carbon footprint, including energy efficiency measures, renewable energy, and the use of biomass energy.

The company’s renewable energy program includes solar power, wind power, and biomass energy. The company has set a target to source 50% of its energy from renewable sources by 2025. The company has also entered into a corporate PPA to source renewable energy from wind farms.

Dr. Reddy’s Laboratories Ltd. is committed to reducing its carbon emissions from transportation. The company has implemented a green logistics program to reduce its carbon emissions from transportation. The program includes the use of electric vehicles, hybrid vehicles, and biofuel-powered vehicles.

Overall, Dr. Reddy’s Laboratories Ltd. is a leader in sustainability and decarbonisation in the generic pharma sector. The company’s commitment to sustainability and decarbonisation is a testament to its mission to provide affordable and accessible healthcare solutions to people around the world.